RxDoctor Payments DataLook up a doctor →

Nick Vatakis

New York, NYNPI 1285835637

Payments from drug & device makers

$5,580,447in general payments, 2019–2025

Across 545 payments — averaging $10,239 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$1.1M
  • Sage Therapeutics, LLC$966K
  • Axsome Therapeutics, Inc.$578K
  • Pfizer$485K
  • Imbrium Therapeutics L.p.$454K
  • Janssen Research & Development, LLC$409K
  • plus $1.6M from 13 others
$4,711in research payments, 2019–2025

Across 9 payments — averaging $523.48 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Pfizer$4K
  • Otsuka Pharmaceutical Development & Commercialization, Inc.$1K

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)82$1,075,291
Sage Therapeutics, LLC77$966,491
Axsome Therapeutics, Inc.13$578,154
Pfizer33$484,899
Imbrium Therapeutics L.p.20$454,275
Janssen Research & Development, LLC20$409,478
Biohaven Pharmaceutical Holding Company Ltd.11$374,517
Otsuka Pharmaceutical Development & Commercialization, Inc.14$358,345
Acadia Pharmaceuticals Inc31$230,840
Supernus Pharmaceuticals, Inc.12$194,544
AbbVie(2 entities)33$189,166
Alkermes, Inc.61$84,775
Ipsen Innovation89$83,110
Eisai Inc.21$47,880
Novo Nordisk AS17$24,079
Boehringer Ingelheim International GmbH7$12,026
Biohaven Pharmaceuticals, Inc.1$6,200
Corcept Therapeutics2$5,627
Merck1$750

Where these figures come from

Is this you, or does something look wrong? →